Literature DB >> 29566560

Overcoming problems of poor drug penetration into bacteria: challenges and strategies for medicinal chemists.

Davide Benedetto Tiz1, Danijel Kikelj1, Nace Zidar1.   

Abstract

INTRODUCTION: Bacterial cell walls and membranes provide essential protection for bacteria against environmental influences. Different bacteria possess different cell envelopes and understanding each of these structures is crucial for the design of effective antibacterial drugs whose targets are intracellular. Optimal properties of drugs that are required for their entry into bacteria are still hard to predict. The guidelines that are suitable and well established for the penetration of a drug into eukaryotic cells are poorly adaptable to the complex world of pathogens. Areas covered: The factors that govern the penetration of anti-infection drugs into bacteria are examined and the available strategies to overcome this therapeutically very important barrier are reviewed. The areas covered include optimization of the physicochemical properties of compounds, utilization of iron-chelating compounds, i.e. siderophores, the use of efflux pump inhibitors, and of carriers such as liposomes. Expert opinion: Although several rules governing permeation have recently been proposed for effective antibacterial drugs, none of them has been so far established as the 'golden' rule. Thus, new research is needed to find a more general approach on how to increase the concentration of antibacterial compounds in bacterial cells.

Entities:  

Keywords:  Antibacterial; bacterial cell envelope; bacterial cell wall; drug entry; efflux pump; permeability; physicochemical properties; siderophore

Mesh:

Substances:

Year:  2018        PMID: 29566560     DOI: 10.1080/17460441.2018.1455660

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  7 in total

Review 1.  Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistance.

Authors:  Erik M Larsen; R Jeremy Johnson
Journal:  Drug Dev Res       Date:  2018-10-10       Impact factor: 4.360

2.  Induction of Antibacterial Metabolites by Co-Cultivation of Two Red-Sea-Sponge-Associated Actinomycetes Micromonospora sp. UR56 and Actinokinespora sp. EG49.

Authors:  Mohamed S Hifnawy; Hossam M Hassan; Rabab Mohammed; Mohamed M Fouda; Ahmed M Sayed; Ahmed A Hamed; Sameh F AbouZid; Mostafa E Rateb; Hani A Alhadrami; Usama Ramadan Abdelmohsen
Journal:  Mar Drugs       Date:  2020-05-05       Impact factor: 5.118

Review 3.  Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs?

Authors:  Kokob H Negash; James K S Norris; James T Hodgkinson
Journal:  Molecules       Date:  2019-09-11       Impact factor: 4.411

4.  Antibacterial Effect and Mode of Action of Flavonoids From Licorice Against Methicillin-Resistant Staphylococcus aureus.

Authors:  Shuai-Cheng Wu; Zhi-Qiang Yang; Fei Liu; Wen-Jing Peng; Shao-Qi Qu; Qian Li; Xiang-Bin Song; Kui Zhu; Jian-Zhong Shen
Journal:  Front Microbiol       Date:  2019-11-05       Impact factor: 5.640

Review 5.  Aminoacyl-tRNA Synthetases as Valuable Targets for Antimicrobial Drug Discovery.

Authors:  Luping Pang; Stephen D Weeks; Arthur Van Aerschot
Journal:  Int J Mol Sci       Date:  2021-02-10       Impact factor: 5.923

6.  A Novel Antimicrobial Peptides From Pine Needles of Pinus densiflora Sieb. et Zucc. Against Foodborne Bacteria.

Authors:  Junho Lee; Hee Kyoung Kang; Hyeonsook Cheong; Yoonkyung Park
Journal:  Front Microbiol       Date:  2021-05-20       Impact factor: 5.640

7.  Refining the structure-activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms.

Authors:  Joana Magalhães; Nina Franko; Giannamaria Annunziato; Marco Pieroni; Roberto Benoni; Anna Nikitjuka; Andrea Mozzarelli; Stefano Bettati; Anna Karawajczyk; Aigars Jirgensons; Barbara Campanini; Gabriele Costantino
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.